SEC Filing

Investor Contacts

Katherine A. Littrell, PhD, RN
Vice President, Investor Relations

Diane H. Schrick
Senior Director, Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 7892
U.S.: +1 650 496 2800

SEC Filing Details

Document Details

Form
Filing Date
Jan 19, 2012
Document Date
Jan 19, 2012
Form Description
424B7    
Filing Group
Registration Statements
Company
Jazz Pharmaceuticals plc
Issuer
Jazz Pharmaceuticals plc